Image

Asia-Pacific Heart Failure Software Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Aug 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 217
  • No of Figures: 31
  • Healthcare
  • Published Report
  • Aug 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 217
  • No of Figures: 31

Asia-Pacific Heart Failure Software Market, By Type (Knowledge-Based, and Non-Knowledge Based ), Delivery Mode (On-Premises, Cloud-Based Systems, and Web-Based), Platform (Standalone, and Integrated), Supportive Devices (Desktops, Tablets, and Others ), Features (Heart Monitoring Activity, Tracking Periodic Tests, Review Progress, Diagnosis, and Therapy Monitoring, Diary Management Tool, and Others),  End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tenders, and Third-Party Distribution), Country (China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast To 2028.

Asia-Pacific Heart Failure Software Market Market Analysis and Insights: Asia-Pacific Heart Failure Software Market

The Asia-Pacific heart failure software market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.2% in the forecast period of 2021 to 2028 and is expected to reach USD 1,185.83 million by 2028. Increasing incidence of heart-related diseases across the globe act as a driver for the heart failure software market growth.

Heart failure is called congestive heart failure (CHF). This happens when the heart is inadequate to flow amply to control blood flow to meet the body's needs. Congestive heart failure is a complex disorder having certain signs and symptoms which are the result of structural and functional cardiac aberrations. Heart failure is mainly called the part in which flowing increases around the heart and it leads to force unproductively. Heart failure software is structured to manage patients carefully and accurately.

Asia-Pacific heart failure software market has developed as a result of technological advancements in software and increased accessibility to personal healthcare. On the other hand, the high cost and non-affordability of heart failure software have hampered the market's expansion. Increasing demand for access to patient health records (PHR/ PHI) is expected to create various opportunities for the growth of Asia-Pacific heart failure software market. This would tend to keep the future of the market strong and advanced.

The heart failure software market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the heart failure software market scenario, contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Heart Failure Software Market Scope and Market Size

Asia-Pacific heart failure software market is segmented based on the type, delivery mode, platform, supportive device, features, end-user, and distribution channel. The growth among segments helps you analyze niche pockets of development and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, Asia-Pacific heart failure software market is segmented into knowledge-based, and non-knowledge-based. Both knowledge-based and non-knowledge-based segments are sub-segmented into on-premises, cloud-based systems, and web-based. In 2021, a knowledge-based segment is expected to dominate the market as it gives customers to chance of solving their problems without enterprise help.
  • On the basis of delivery mode, Asia-Pacific heart failure software market is segmented into on-premises, cloud-based systems, and web-based. The on-premises, cloud-based systems, and web-based segment are sub-segmented into desktops, tablets, and others. In 2021, the on-premise segment is expected to dominate the market due to the wide usage of on-premises software as it doesn’t require users to have an internet connection to access data. Though most businesses rely on the internet to conduct business, there’s always a fear that the loss of a connection could harm productivity and make it impossible to access crucial data.
  • On the basis of platform, Asia-Pacific heart failure software market is segmented into standalone and integrated. In 2021, the standalone segment is expected to dominate the market as standalone software is run alone, without the support of the need to interact with other software.
  • On the basis of supportive devices, the Asia-Pacific heart failure software market is segmented into desktops, tablets, and others. In 2021, the desktop segment is expected to dominate the market as desktop devices have portrait orientations so content can stretch across a screen, and often multiple messages or images can live comfortably in such a wide space.
  • On the basis of features, the Asia-Pacific heart failure software market is segmented into heart monitoring activity, tracking periodic tests, review progress, diagnosis and therapy monitoring, diary management tool, and others. Diary management tool segment sub-segmented into scheduling and reminder functions. In 2021, the heart monitoring activity segment is expected to dominate the market owing to its increasing demand for cardiac event monitor devices that control the electric activity of heart.
  • On the basis of end user, Asia-Pacific heart failure software market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and others. Hospital segment sub-segmented into long-term care hospitals, and acute care hospitals. In 2021, the hospital is expected to dominate the market owing to the increasing adoption of electronic health records (EHR) and remote patient monitoring systems.
  • On the basis of distribution channel, Asia-Pacific heart failure software market is segmented into direct tenders and third party distribution. In 2021, the direct tenders segment is expected to dominate the market as the knowledge base dominated the market due to SaaS, AI and machine learning being a part of it. Hence, top companies directly approach the hospital's management for tenders.

Asia-Pacific Heart Failure Software Market Country Level Analysis

The heart failure software market is analyzed, and market size information is provided by the type, delivery mode, platform, supportive device, features, end user, and distribution channel as referenced above.

The countries covered in the heart failure software market report are the type, delivery mode, platform, supportive device, features, end-user, and distribution channel. Germany dominates the market due to the Rising awareness about personal health amongst the population.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific can brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Increasing Incidence of Heart-related Diseases are boosting the Market Growth of Asia-Pacific Heart Failure Software Market.

Asia-Pacific heart failure software market also provides you with a detailed market analysis for every country's growth in the particular market. Additionally, it provides detailed information regarding the market players’ strategy and their geographical presence. The data is available for the historical period 2010 to 2019.

Competitive Landscape and Asia-Pacific Heart Failure Software Market Share Analysis

Heart failure software market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the heart failure software market.

The major companies which are dealing in Asia-Pacific heart failure software market are Cerner Corporation, 4S Information Systems Ltd., Axis Clinical Software, Inc., Medtronic, CV Medical Software, and ABBOTT, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product development and collaboration are also initiated by the companies worldwide, which are also accelerating the heart failure software market.

For instance,

  • In June 2021, Medtronic announced a clinical trial for the STROKE AF trial determining the Reveal LINQ Insertable Cardiac Monitor (ICM) superiority to detect abnormal heartbeats, otherwise known as atrial fibrillation (AF). Medtronic offers the most comprehensive range of innovative medical technology for the interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias, developed in collaboration with the world's leading clinicians, researchers, and scientists. The company strives to provide high-quality products and services that provide clinical and economic value to healthcare consumers and providers..
  • In July 2019, Cerner Corporation introduced a new era of health care innovation with Amazon Web Services, Inc. to accelerate health care innovation for accelerating Artificial Intelligence (AI), Machine Learning (ML), and other cutting-edge innovations for better patient outcomes. The company enhanced its voice recognition and natural language process technologies to deliver profit.

Joint venture, business expansion, award and recognition, agreements, and other strategies by the market player are enhancing the company footprints in the heart failure software market which also provides the benefit for the organization’s profit growth.


SKU-
Why Choose Us


Frequently Asked Questions